|
English
|
µð·ºÅ丮°Ë»ö
ȨÆäÀÌÁö µî·Ï
/
¼öÁ¤
¼¼°è»ê¾÷Àç»ê±ÇÁ¦µµ
Á¸¼Ó±â°£ÀÚµ¿»êÃâ
Çѱ¹Æ¯Çã°Ë»ö
¹Ì±¹Æ¯Çã°Ë»ö
ÀϺ»Æ¯Çã°Ë»ö
¹«·á»óÇ¥Á¶»ç¼ºñ½º
ƯÇã¹ø¿ª
ƯÇãÁ¤º¸Á¶»ç
ƯÇã»óÇ°º¸±â
ÃßõƯÇã»óÇ°
±â¼úÀÌÀüÀåÅÍ
±â¼úµµÀÔÀåÅÍ
³ªÀÇ Å¬·´
Ŭ·´¸®½ºÆ®
Ŭ·´¸¸µé±â
¼ºñ½º¸ðÀ½
TotalPatCenter
PatDir
PatCalendar
PatDiary
PatNews
PatDic
PatLaw
Àλ縻
¾÷¹«¹æħ
¼ºñ½ººÐ¾ß
¼ºñ½ººñ¿ë
Hunter µÇ±â
»ó±Ý ´äº¯Çϱâ
»ó±ÝÅä·Ð½Ç
»ó±Ý µî·ÏÇϱâ
±¹³»Ãâ¿ø
ƯÇãÃâ¿ø½Åû
¹«·á»óÇ¥Á¶»ç
À¯·á»óÇ¥Á¶»ç
»óÇ°ºÐ·ùÇ¥
Ãâ¿øºñ¿ë¾È³»
ƯÇã¼Àû Best10
Ãßõµµ¼
½Å°£µµ¼
Àå¹Ù±¸´Ï
±¸¸Å³»¿ª
Help Desk
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
Ȩµî·Ï
ÀÌ¿ë¾È³»
°í°´¼¾ÅÍ
»çÀÌÆ®¸Ê
À¥»çÀÌÆ®¸í
»çÀÌÆ®¼³¸í
µµ¸ÞÀθí
¹ø¿ª¼¾ÅÍ ¼Ò°³
¼ºñ½º ¾È³»
ºñ¿ë ¾È³»
°øº¸·Î ¹è¿ì´Â
ƯÇ㿵¾î ¹è¿ì±â (I)
ÇÑ±Û Ç¥ÇöÀÇ
ƯÇ㿵¾î ¹è¿ì±â (II)
¿µ¹® Ç¥ÇöÀÇ
ƯÇ㿵¾î ¹è¿ì±â (¥²)
¿µÀÛ Ç¥ÇöÀÇ
ƯÇ㿵¾î ¹è¿ì±â(¥³)
°ßÀûÀÇ·Ú
¹ø¿ªÀÇ·Ú
¹ø¿ª»çµî·Ï
Q&A
E-mail
°æ±âÅ×Å©³ëÆÄÅ©
Àü¹®¹ø¿ªÁöÁ¤¾÷ü
Áö½ÄÀç»ê¹ø¿ª(IPT)
Äļҽÿò¾÷ü
+ Patzine ½Åû
À̸§ :
¸ÞÀÏ :
°³ÀÎÁ¤º¸Ãë±Þ
µ¿ÀÇ
´º½º·¹Å͸¦ º¸³»µå¸³´Ï´Ù.
ȸ¿ø¼ö :
331112
¸í
¹¯°í ´äÇϱâ
´äº¯Çϱâ
ÀÛ¼ºÀÚ
E-mail
Á¦¸ñ
ºñ¹Ð¹øÈ£
* ¼öÁ¤, »èÁ¦½Ã ÇÊ¿ä
³»¿ë
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - psh´Ô²²¼ ¾²½Å³»¿ë... > ´äº¯¿¡ °¨»çµå¸³´Ï´Ù. > Á¦°¡ ¹ø¿ªÀ» ºÎŹµå¸° ºÎºÐ¿¡ ´ëÇÑ ³»¿ëÀ» ÀÚ¼¼È÷ ¿Ã¸®Áö ¸øÇÑ°Í °°½À´Ï´Ù. »ó¼¼ÇÑ ³»¿ëÀº ¾Æ·¡¿Í °°À¸¸ç, ±× Á¦¸ñÀ» ¾î¶»°Ô Çؼ®À» ÇØ¾ß µÉÁö Àǹ®ÀÔ´Ï´Ù. > ±×¿¡ ´ëÇÑ ³»¿ëÀº ´Ù½ÃÇѹø ¿Ã¸®¿À´Ï ¹ø¿ªÀ» ºÎŹ µå¸®°Ú½À´Ï´Ù. > ¾Æ¿ï·¯, ±×¿Í À¯»çÇÑ ³»¿ë¿¡ ´ëÇÑ Á¦¸ñÀÌ ¸î°³ Àִµ¥ ÇöÀç ƯÇã¾÷¹«¸¦ º¸°íÀÖ´Â Àú¿¡°Ô Áß¿äÇÑ ºÎºÐÀÌ¶ó ¿°Ä¡ ºÒ±¸ÇÏ°í ºÎŹµå¸³´Ï´Ù. > -------------------------------------------------------- > 1. Patent Department Clearance > 2. Review Responsibility and Approval Authority > 3. Clearance by Other Departments > 4. Publication Approval Procedure > -------------------------------------------------------- > > Title : Patent Department Clearance > > The right to protect important know-how, secret processes and formulae can be forfeited by publication. The right to a U.S. or foreign patent can be lost by premature publication. The patent department, therefore, has a number of general concerns including: > - timing of publication with respect to the existing patent program on the subject matter; > - disclosure in the manuscript of new inventions; > - possible conflicts with or violations of third-party agreements on the exchange or release of technical information; > - alerting management to the possible loss of valuable know-how and competitive advantage by publication; and > - alerting others to possible claims of patent infringement against the corporation. > > The relationship between publications and patents is a complex one. patents themselves are publications, and their prompt issuance in some countries requires the exercise of judgment in foreign to avoid premature disclosure of inventions and know-how to competitions. sometimes it is even desirable to publish promptly instead of obtaining a patent. > > R&D/Technical/Medical management must, therefore, seek the written consent of the divisional patent counsel or the corporate patent counsel for every proposed technical paper and presentation. The divisional or corporate patent counsel will review the proposed paper or presentation primarily to ensure that valuable property rights, particularly patent and trade secret rights, are not lost by inadvertent or premature disclosure. > - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
±¤°í ¹× À̺¥Æ® ¹®ÀÇ
|
»ç¾÷Á¦ÈÞ
|
ȸ»ç¼Ò°³
|
ȨÆäÀÌÁö Á¦ÀÛ/ƯÇã e-biz
dowon.com
|
dowon.co.kr
|
ktt114.kr
Copyright ¨Ï 2001
Dowon International.
All rights reserved.
Designed by
DOWON.NET